Mutant selectivity and combinations of a phosphoinositide 3 Kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer

• 收藏
• 分享

专利权人:

F. Hoffmann-La Roche AG

发明人:

BELVIN, Marcia,FRIEDMAN, Lori,SAMPATH, Deepak,WALLIN, Jeffrey

申请号：

AU2018202503

公开号：

AU2018202503A1

申请日:

2018.04.10

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

#$%^&*AU2018202503A120180510.pdf#####Abstract Methods and compositions are provided for treating hyperproliferative disorders in patients with a P13K inhibitor, GDC-0032 as a single agent or in combination with 5 chemotherapeutic agents. N -N GDC-0032 10134432 1 (GHMatters) P98407.AU.1

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/